Susquehanna International Group
PBMWW

Susquehanna International Group’s Psyence Biomedical Warrant PBMWW Stock Holding History

Susquehanna International Group’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212 Buy
+10,119
New +$290 ﹤0.01% 13272
2026
Q1 		– Sell
-73,027
Closed -$1.44K – 14279
2025
Q4 		$1.44K Sell
73,027
-34,882
-32% -$879 ﹤0.01% 12136
2025
Q3 		$2.7K Sell
107,909
-29,533
-21% -$744 ﹤0.01% 12162
2025
Q2 		$2.78K Buy
137,442
+116,519
+557% +$1.86K ﹤0.01% 12477
2025
Q1 		$354 Buy
+20,923
New +$398 ﹤0.01% 12349

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Susquehanna International Group's PBMWW Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Psyence Biomedical Warrant (PBMWW) in Q2 2026: 10,119 shares worth $212. The stake represents ﹤0.01% of the portfolio and ranks #13272 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in PBMWW as recently as Q4 2025.

Susquehanna International Group first reported a position in PBMWW in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.78K in Q2 2025. 18 funds tracked by Wall St. Rank hold PBMWW as of Q2 2026.

  • Susquehanna International Group held 10,119 shares of Psyence Biomedical Warrant worth $212 as of Q2 2026.
  • Psyence Biomedical Warrant was a new Susquehanna International Group position in Q2 2026.
  • Psyence Biomedical Warrant made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13272 holding.
  • Susquehanna International Group first reported a position in Psyence Biomedical Warrant in Q1 2025 and has held it in 5 quarters since.
  • Susquehanna International Group's Psyence Biomedical Warrant position peaked at $2.78K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.